Treatment deviating from guidelines does not influence status epilepticus prognosis

Journal of Neurology

Volumn 260, Issue 2, 2013, Pages 421-428

  Rossetti, Andrea O ^a   Alvarez, Vincent ^a   Januel, Jean Marie ^b   Burnand, Bernard ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Cohort; Mortality; Outcome; Predictor

Indexed keywords

CLONAZEPAM; ETIRACETAM; LORAZEPAM; MIDAZOLAM; PHENYTOIN; PROPOFOL; THIOPENTAL; VALPROIC ACID;

ADULT; ARTICLE; COMORBIDITY; DISEASE SEVERITY; EPILEPTIC STATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATUS EPILEPTICUS SEVERITY SCORE;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHI-SQUARE DISTRIBUTION; DISABLED PERSONS; ELECTROENCEPHALOGRAPHY; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; STATUS EPILEPTICUS; YOUNG ADULT;

EID: 84878865393     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6644-x     Document Type: Article

References (38)

1. Commission on Epidemiology and Prognosis, International League Against Epilepsy (1993) Guidelines for epidemiologic studies on epilepsy. Epilepsia 34:592-596
2. Alvarez V, Januel JM, Burnand B, Rossetti AO (2012) Role of comorbidities in outcome prediction after status epilepticus. Epilepsia 53:e89-e92
3. Aranda A, Foucart G, Ducasse JL, Grolleau S, McGonigal A, Valton L (2010) Generalized-convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice. Epilepsia 51:2159-2167
4. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
5. Coeytaux A, Jallon P, Galobardes B, Morabia A (2000) Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 55:693-697
6. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D (1996) A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46:1029-1035
7. Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL (2009) Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 50:1566-1571
8. Govoni V, Fallica E, Monetti VC, Guerzoni F, Faggioli R, Casetta I, Granieri E (2007) Incidence of Status Epilepticus in Southern Europe: a Population Study in the Health District of Ferrara, Italy. Eur Neurol 59:120-126
9. Holtkamp M (2011) Treatment strategies for refractory status epilepticus. Curr Opin Crit Care 17:94-100
10. Holtkamp M, Othman J, Buchheim K, Meierkord H (2005) Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 76:534-539
11. Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, Katsarou N, Hamer HM (2001) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 42:714-718
12. Koubeissi M, Alshekhlee A (2007) In-hospital mortality of generalized-convulsive status epilepticus: a large US sample. Neurology 69:886-893
13. Leppert D, Stoeckli HR, Fuhr P (2005) Directives pour le traitement de l'état de mal épileptique. Schweizerische Aerztezeitung 86. www.saez.ch/status-epilepticus-f.pdf
14. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA (1997) Short-term mortality after a first episode of status epilepticus. Epilepsia 38:1344-1349
15. Lowenstein DH, Alldredge BK (1998) Status epilepticus. N Engl J Med 338:970-976
16. Lowenstein DH, Bleck T, Macdonald RL (1999) It's time to revise the definition of status epilepticus. Epilepsia 40:120-122
17. Marchi N, Granata T, Freri E, Ciusani E, Ragona F, Puvenna V, Teng Q, Alexopolous A, Janigro D (2011) Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS ONE 6:e18200
18. Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, Holtkamp M (2010) EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 17:348-355
19. Minicucci F, Muscas G, Perucca E, Capovilla G, Vigevano F, Tinuper P (2006) Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy. Epilepsia 47(Suppl 5):9-15
20. Muayqil T, Rowe BH, Ahmed SN (2007) Treatment adherence and outcomes in the management of convulsive status epilepticus in the emergency room. Epileptic Disord 9:43-50
21. Neligan A, Shorvon SD (2011) Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review. Epilepsy Res 93:1-10
22. Novy J, Logroscino G, Rossetti AO (2010) Refractory status epilepticus: a prospective observational study. Epilepsia 51:251-256
23. Outin H, Blanc T, Vinatier I (2009) Emergency and intensive care unit management of status epilepticus in adult patients and children (new-born excluded). Societe de reanimation de langue francaise experts recommendations. Rev Neurol (Paris) 165:297-305
24. Rabinstein AA (2010) Management of status epilepticus in adults. Neurol Clin 28:853-862
25. Ravizza T, Balosso S, Vezzani A (2011) Inflammation and prevention of epileptogenesis. Neurosci Lett 497:223-230
26. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB (2006) Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 77:611-615
27. Rossetti AO, Logroscino G, Bromfield EB (2005) Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 62:1698-1702
28. Rossetti, AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB (2008) Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 255:1561-1566
29. Rossetti AO, Lowenstein DH (2011) Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 10:922-930
30. Rossetti AO, Novy J, Ruffieux C, Olivier P, Foletti GB, Hayoz D, Burnand B, Logroscino G (2009) Management and prognosis of status epilepticus according to hospital setting: a prospective study. Swiss Med Wkly 139:719-723
31. Scholtes FB, Renier WO, Meinardi H (1994) Generalized-convulsive status epilepticus: causes, therapy, and outcome in 346 patients. Epilepsia 35:1104-1112
32. Shneker BF, Fountain NB (2003) Assessment of acute morbidity and mortality in non-convulsive status epilepticus. Neurology 61:1066-1073
33. Shorvon S (2011) The treatment of status epilepticus. Curr Opin Neurol 24:165-170
34. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W (2012) Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 366:591-600
35. Towne AR, Pellock JM, Ko D, DeLorenzo RJ (1994) Determinants of mortality in status epilepticus. Epilepsia 35:27-34
36. van Rijckevorsel K, Boon P, Hauman H, Legros B, Ossemann M, Sadzot B, Schmedding E, van Zandijcke M (2006) Standards of care for non-convulsive status epilepticus: Belgian consensus recommendations. Acta Neurol Belg 106:117-124
37. Vignatelli L, Rinaldi R, Baldin E, Tinuper P, Michelucci R, Galeotti M, de Carolis P, D'Alessandro R (2008) Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts. J Neurol 255:197-204
38. Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC (2002) Incidence and mortality of generalized-convulsive status epilepticus in California. Neurology 58:1070-1076